XML 80 R54.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock-based Compensation and Benefits (Tables)
12 Months Ended
Dec. 31, 2024
Stock-based Compensation and Benefits  
Schedule of weighted average assumptions using Black-Scholes option-pricing model

The Company issued no stock options during 2024. Below are the weighted average assumptions used in the Black-Scholes option pricing model to determine fair value of the Company’s stock options granted in 2023 and 2022:

2023

2022

Weighted average fair value

$

9.01

$

11.14

Weighted average risk-free interest rate(1)

3.57%

2.69%

Expected volatility(2)

32.48%

31.16%

Expected term (years)(3)

6.05

6.04

Dividend yield(4)

2.99%

2.24%

(1)

    

The risk-free rate for the expected term of the options was based on the U.S. Treasury yield curve at the date of grant and based on the expected term.

(2)

    

Expected volatility was calculated using historical volatility of the Company’s stock price for a period commensurate with the expected term of the options.

(3)

    

The expected term was estimated to be the average of the contractual vesting term and time to expiration.

(4)

    

The dividend yield was calculated in accordance with the Company’s dividend policy at the time of grant.

Summary of Option Activity

The following table summarizes stock option activity for 2024:

Weighted

average

Weighted

remaining

average

contractual

Aggregate

exercise

term in

intrinsic

Options

price

years

value

Outstanding at December 31, 2023

755,546

$

30.95

5.79

$

5,270

Granted

Exercised

(177,379)

24.48

Forfeited

(14,175)

34.24

Outstanding at December 31, 2024

563,992

32.90

5.37

5,759

Options exercisable at December 31, 2024

472,290

32.36

4.86

5,072

Options vested and expected to vest

558,813

32.88

5.34

5,716

Summary of outstanding stock options

The following table summarizes the Company’s outstanding stock options:

Options outstanding

Options exercisable

Weighted average

Number

remaining contractual

Weighted average

Number

Weighted average

Range of exercise price

outstanding

life (years)

exercise price

exercisable

exercise price

$

18.00

-

22.99

11,184

0.94

$

19.43

11,184

$

19.43

23.00

-

27.99

116,194

5.24

23.15

116,194

23.15

28.00

-

32.99

69,818

3.18

32.63

69,818

32.63

33.00

-

37.99

230,144

5.45

33.84

163,814

33.99

38.00

and above

136,652

6.81

40.84

111,280

40.72

Summary of Restricted Stock Activity

The following table summarizes restricted stock and performance stock unit activity during 2024 and 2023:

Weighted

Weighted

Restricted

average grant-

Performance

average grant-

stock shares

date fair value

stock units

date fair value

Unvested at December 31, 2022

165,137

$

38.28

155,857

$

33.81

Granted

186,546

31.16

79,215

30.57

Adjustment due to performance

18,664

25.94

Vested

(101,171)

34.42

(74,142)

26.55

Forfeited

(9,928)

36.42

(7,812)

34.58

Unvested at December 31, 2023

240,584

$

34.47

171,782

$

34.56

Granted

186,050

35.43

79,254

35.24

Adjustment due to performance

(530)

35.75

Vested

(108,762)

35.85

(46,490)

37.82

Forfeited

(25,858)

35.97

(5,752)

32.66

Unvested at December 31, 2024

292,014

$

34.43

198,264

$

34.31